Shandong Lukang Pharmaceutical Co.,Ltd. (SHA:600789)

Market Cap	9.15B +6.6%
Revenue (ttm)	6.19B +1.8%
Net Income	188.75M -52.9%
EPS	0.21 -53.0%
Shares Out	1.05B
PE Ratio	41.32
Forward PE	n/a
Dividend	0.13 (1.51%)
Ex-Dividend Date	n/a

Volume	13,252,785
Average Volume	16,239,621
Open	8.71
Previous Close	8.75
Day's Range	8.60 - 8.75
52-Week Range	8.60 - 11.97
Beta	0.23
RSI	34.53
Earnings Date	Apr 25, 2026

About SHA:600789

Shandong Lukang Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in China. The company provides analgesics and antipyretics; gastrointestinal; endocrine; cardio-cerebrovascular; anti-infective; and other human formulation products. It offers human and veterinary active pharmaceutical ingredient; veterinary formulation; bio-pesticides; and amino acid. The company also exports its products to European Union, the United States, the United Kingdom, Russia, India, Brazil, Japan, and internationally. The company was formerly known as Jini...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1966
• Employees: 6,388
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600789

Financial Performance

In 2024, SHA:600789's revenue was 6.23 billion, an increase of 1.41% compared to the previous year's 6.15 billion. Earnings were 394.62 million, an increase of 60.30%.